Molecular Partners Ag (MOLN) EBITDA Margin (2020 - 2024)
Molecular Partners Ag (MOLN) recorded EBITDA Margin of 360643.33% in Q4 2024, up 362198.18 percentage points from -1554.84% a year earlier and up 362698.84 percentage points from the prior quarter.
Powered by 
Analysis
Molecular Partners Ag (MOLN) EBITDA Margin (2020 - 2024) Analysis & Trends
For FY2024, Molecular Partners Ag reported EBITDA Margin of 1271.38%, up 2105.25 percentage points from FY2023.
- Annual EBITDA Margin has a five-year change of +1439.12 percentage points (FY2019 to FY2024).
- Across earlier years, EBITDA Margin came in at -833.87% in FY2023 (-896.64 pp), 62.76% in FY2022 (+686.64 pp), -623.88% in FY2021 (-30.57 pp) and -593.31% in FY2020 (-425.57 pp).
- The Q4 2024 figure is the highest quarterly EBITDA Margin in data going back to Q4 2020.
- On a year-over-year basis, EBITDA Margin rose in three of the last eight quarters, with an average year-over-year change of +44766.10 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 362198.18 percentage points in Q4 2024, against a drop of 3633.12 percentage points in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -2055.51% (Q3 2024), -991.17% (Q2 2024) and -557.09% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Molecular Partners Ag | 138.65 Mn | -292.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -2,055.51% |
| Jun 30, 2024 | -991.17% |
| Mar 31, 2024 | -557.09% |
| Dec 31, 2023 | -1,554.84% |
| Sep 30, 2023 | -507.08% |
| Jun 30, 2023 | -3,681.69% |
| Mar 31, 2023 | -474.69% |
| Dec 31, 2022 | -532.49% |
| Sep 30, 2022 | -596.79% |
| Jun 30, 2022 | -48.57% |
| Mar 31, 2022 | 88.65% |
| Dec 31, 2021 | -840.47% |
| Sep 30, 2021 | -345.71% |
| Jun 30, 2021 | -453.69% |
| Mar 31, 2021 | -1,829.07% |
| Dec 31, 2020 | -6,206.41% |
API Access
Molecular Partners Ag EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();